SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-019658
Filing Date
2018-08-07
Accepted
2018-08-07 08:01:16
Documents
50
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 ALNA-10Q-20180630 alna-10q_20180630.htm 10-Q 1790947
2 EX-31.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO EXCHANGE ACT RU alna-ex311_7.htm EX-31.1 16798
3 EX-31.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO EXCHANGE ACT RU alna-ex312_6.htm EX-31.2 16800
4 EX-32.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFF alna-ex321_8.htm EX-32.1 10342
  Complete submission text file 0001564590-18-019658.txt   4639191

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT alna-20180630.xml EX-101.INS 791720
6 XBRL TAXONOMY EXTENSION SCHEMA alna-20180630.xsd EX-101.SCH 32922
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alna-20180630_cal.xml EX-101.CAL 32225
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alna-20180630_def.xml EX-101.DEF 109113
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE alna-20180630_lab.xml EX-101.LAB 258043
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alna-20180630_pre.xml EX-101.PRE 191042
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38268 | Film No.: 18996345
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences